Skip to content
Living
GLP1
Findings
Treatments
Trials
NMA lab
Protocol
Inventory
Methods
Learn
Data
Home
/
Treatments
/
Exenatide flexible dose injection twice daily
Short acting GLP-1 receptor agonist (injectable)
Exenatide flexible dose injection twice daily
EXEN_SC_FLEX_5-10_BID
Mechanism
GLP-1 receptor agonist; exenatide twice daily and lixisenatide (half life about 2 to 4 hours); beinaglutide (recombinant human GLP-1; half life of minutes)
Trials
0
Participants in these arms
0
Related
All doses pooled: Exenatide injection
Exenatide 10 ug subcutaneous twice daily
Exenatide 10 µg injection
Exenatide 5 ug subcutaneous twice daily
Exenatide 5 µg injection
Exenatide 2.5 µg injection twice daily
Exenatide 1.25 µg injection
Exenatide 2.5 µg injection
Trials